Today, the European Commission has negotiated the first contract on behalf of the EU Member States, with a pharmaceutical company entered into force following the formal signature between AstraZeneca and the Commission.
The agreement will allow the purchase of a vaccine against COVID-19 for all the Member States of the EU and the donation to lower and middle-income countries or the re-direction to other European countries, the European Commission reports on its official website.
Through the contract, all Member States will be able to purchase 300 million doses of the AstraZeneca vaccine, with an option for further 100 million doses, to be distributed on a population-based pro-rata basis.
The Commission discusses similar agreements with other vaccine manufacturers and has concluded successful exploratory talks with Sanofi-GSK on 31 July, Johnson & Johnson, on 13 August, CureVac on 18 August, and Moderna on 24 August.
Elena Trekhlebova
News Author